{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:07:01Z","timestamp":1790705221991,"version":"4.1.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139423","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T18:06:09Z","timestamp":1443809169000},"page":"e0139423","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations"],"prefix":"10.1371","volume":"10","author":[{"given":"Markus","family":"Krauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Tappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schuppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kuepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"Goerlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"issue":"12","key":"ref1","first-page":"1217","article-title":"Drug-Metabolism Research Challenges in the New Millennium: Individual Variability in Drug Therapy and Drug Safety","volume":"26","author":"AYH Lu","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"ref2","first-page":"e13","article-title":"A Mechanistic, Model-Based Approach to Safety Assessment in Clinical Development","volume":"1","author":"J Lippert","year":"2012","journal-title":"CPT: pharmacomet syst pharmacol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmpb.2004.01.001","article-title":"Non-linear mixed-effects pharmacokinetic\/pharmacodynamic modelling in NLME using differential equations","volume":"76","author":"CW Torn\u00f8e","year":"2004","journal-title":"Comput Meth Prog Bio"},{"issue":"10","key":"ref4","first-page":"401","article-title":"Basic concepts of pharmacokinetic\/pharmacodynamic (PK\/PD) modelling","volume":"35","author":"B Meibohm","year":"1997","journal-title":"Int J Clin Pharm Th"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1198\/1085711032697","article-title":"Nonlinear models for repeated measurement data: an overview and update","volume":"8","author":"M Davidian","year":"2003","journal-title":"J Agr Biol Envir St"},{"key":"ref6","first-page":"e120","article-title":"Evaluation of 4[beta]-Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism-Based Pharmacometric Model","volume":"3","author":"TA Leil","year":"2014","journal-title":"CPT: pharmacomet syst pharmacol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1208\/s12248-012-9368-z","article-title":"Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infection","volume":"14","author":"R Jin","year":"2012","journal-title":"AAPS J"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2125.2012.04292.x","article-title":"Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis","volume":"74","author":"N Bouazza","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17425255.3.2.235","article-title":"Whole-body physiologically based pharmacokinetic models","volume":"3","author":"I Nestorov","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ddtec.2004.09.006","article-title":"Physiology-based pharmacokinetic modeling: ready to be used","volume":"1","author":"W Schmitt","year":"2004","journal-title":"Drug Discov Today: Technologies"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science","volume":"51","author":"M Rowland","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"16","key":"ref12","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1021\/jm030999b","article-title":"A physiological model for the estimation of the fraction dose absorbed in humans","volume":"47","author":"S Willmann","year":"2004","journal-title":"J Med Chem"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jps.20322","article-title":"Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases","volume":"94","author":"T Rodgers","year":"2005","journal-title":"J Pharm Sci"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"T Rodgers","year":"2006","journal-title":"J Pharm Sci"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","article-title":"Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs","volume":"34","author":"S Willmann","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/10408440390242324","article-title":"Modeling Interindividual Variation in Physiological Factors Used in PBPK Models of Humans","volume":"33","author":"PS Price","year":"2003","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2133\/dmpk.24.53","article-title":"A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of &apos;bottom-up&apos; vs &apos;top-down&apos; recognition of covariates","volume":"24","author":"M Jamei","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1211\/jpp.61.07.0008","article-title":"Whole\u2010body physiologically based pharmacokinetic population modelling of oral drug administration: inter\u2010individual variability of cimetidine absorption","volume":"61","author":"S Willmann","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10928-006-9018-0","article-title":"Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model","volume":"33","author":"F Yang","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1289\/ehp.1205687","article-title":"Addressing Human Variability in Next-Generation Human Health Risk Assessments of Environmental Chemicals","volume":"121","author":"L Zeise","year":"2013","journal-title":"Environ Health Perspect"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tox.2010.06.007","article-title":"PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals","volume":"278","author":"FY Bois","year":"2010","journal-title":"Toxicology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1289\/ehp.00108s5883","article-title":"Statistical Issues in Toxicokinetic Modeling: A Bayesian Perspective","volume":"108","author":"P Bernillon","year":"2000","journal-title":"Environ Health Perspect"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2009.07.032","article-title":"Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach","volume":"241","author":"WA Chiu","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-9616-1-6","article-title":"Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification","volume":"1","author":"M Krauss","year":"2013","journal-title":"In Silico Pharmacol"},{"key":"ref25","first-page":"1","article-title":"Physiologically based pharmacokinetic modeling of hydrogen cyanide levels in human breath","author":"K Stamyr","year":"2014","journal-title":"Arch Toxicol"},{"key":"ref26","first-page":"1","article-title":"Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach","author":"N Tsamandouras","year":"2014","journal-title":"Pharm Res"},{"key":"ref27","first-page":"1","article-title":"Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach","author":"T Zurlinden","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1478-5382(03)02342-4","article-title":"PK-Sim\u00ae: a physiologically based pharmacokinetic \u2018whole-body\u2019 model","volume":"1","author":"S Willmann","year":"2003","journal-title":"Biosilico"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P","article-title":"Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs","volume":"90","author":"P Poulin","year":"2001","journal-title":"J Pharm Sci"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1023\/B:PHAM.0000003373.72652.c0","article-title":"A physiologic model for simulating gastrointestinal flow and drug absorption in rats","volume":"20","author":"S Willmann","year":"2003","journal-title":"Pharm Res"},{"key":"ref31","author":"M Davidian","year":"1995"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0379-0738(00)00401-1","article-title":"Organ weight in 684 adult autopsies: new tables for a Caucasoid population","volume":"119","author":"GL de la Grandmaison","year":"2001","journal-title":"Forensic Sci Int"},{"key":"ref33","article-title":"Understanding Computational Bayesian Statistics","author":"WM Bolstad","year":"2010"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1020281327116","article-title":"An Introduction to MCMC for Machine Learning","volume":"50","author":"C Andrieu","year":"2003","journal-title":"Machine Learning"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/biomet\/57.1.97","article-title":"Monte Carlo sampling methods using Markov chains and their applications","volume":"57","author":"WK Hastings","year":"1970","journal-title":"Biometrika"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/13-BA801","article-title":"A Vine-copula Based Adaptive MCMC Sampler for Efficient Inference of Dynamical Systems","volume":"8","author":"D Schmidl","year":"2013","journal-title":"Bayesian Anal"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02789703","article-title":"Componentwise adaptation for high dimensional MCMC","volume":"20","author":"H Haario","year":"2005","journal-title":"Comput Statist"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1467-9868.2010.00765.x","article-title":"Riemann manifold Langevin and Hamiltonian Monte Carlo methods","volume":"73","author":"M Girolami","year":"2011","journal-title":"J Roy Stat Soc B"},{"key":"ref39","article-title":"Handbook of Markov Chain","author":"S Brooks","year":"2011"},{"issue":"Suppl 2","key":"ref40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1289\/ehp.00108s2275","article-title":"Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics","volume":"108","author":"FY Bois","year":"2000","journal-title":"Environ Health Perspect"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/01621459.1996.10476708","article-title":"Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions","volume":"91","author":"A Gelman","year":"1996","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1214\/06-BA117A","article-title":"Prior distributions for variance parameters in hierarchical models","volume":"1","author":"A Gelman","year":"2006","journal-title":"Bayesian Anal"},{"issue":"1007","key":"ref43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1098\/rspa.1946.0056","article-title":"An invariant form for the prior probability in estimation problems","volume":"186","author":"H Jeffreys","year":"1946","journal-title":"P Roy Soc Lond A Mat"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/17425255.1.1.159","article-title":"From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools","volume":"1","author":"S Willmann","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"ref45","article-title":"A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks","volume":"2","author":"T Eissing","year":"2011","journal-title":"Front Physio"},{"issue":"2","key":"ref46","first-page":"229","article-title":"Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia","volume":"118","author":"JR Powell","year":"1978","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-197803040-00002","article-title":"Clinical Pharmacokinetics of Theophylline","volume":"3","author":"RI Ogilvie","year":"1978","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0009-9236(03)00013-4","article-title":"Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma","volume":"73","author":"Y Obase","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"ref49","article-title":"NONMEM Users Guide: Part V","author":"A Boeckmann","year":"1994"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences","author":"A Gelman","year":"1992","journal-title":"Stat Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/01621459.1996.10476956","article-title":"Markov chain Monte Carlo convergence diagnostics: a comparative review","volume":"91","author":"MK Cowles","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"ref52","author":"AW Bowman","year":"1997"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models","volume":"13","author":"M Bergstrand","year":"2011","journal-title":"AAPS J"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0278-6915(01)00005-9","article-title":"Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates","volume":"39","author":"J Dorne","year":"2001","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10543400600851898","article-title":"The application of a Bayesian approach to the analysis of a complex, mechanistically based model","volume":"17","author":"F Jonsson","year":"2007","journal-title":"Journal of Biopharmaceutical Statistics"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2193-9616-1-6","article-title":"Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification","volume":"1","author":"M Krauss","year":"2013","journal-title":"In Silico Pharmacology"},{"key":"ref57","first-page":"e4","article-title":"Modeling Interindividual Variability in Physiologically Based Pharmacokinetics and Its Link to Mechanistic Covariate Modeling","volume":"1","author":"W Huisinga","year":"2012","journal-title":"CPT: pharmacomet syst pharmacol"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/clpt.1980.212","article-title":"Theophylline clearance: effect of marked obesity","volume":"28","author":"RA Blouin","year":"1980","journal-title":"Clin Pharm Ther"},{"issue":"9","key":"ref59","first-page":"393","article-title":"Pharmacokinetics of theophylline in obesity","volume":"34","author":"B Zahorska-Markiewicz","year":"1996","journal-title":"Int J Clin Pharm Th"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:55:46Z","timestamp":1567230946000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139423"}},"subtitle":[],"editor":[{"given":"Markos","family":"Leggas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139423","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}